EFFICACY OF LOW-DOSE CYTARABINE-BASED REGIMEN(CAG) FOLLOWED BY AZACITIDINE FOR ELDERLY PATIENTS WITH MDS/AML

被引：0
|
作者：
Tabayashi, Takayuki [1 ]
Takahashi, Yasuyuki [1 ]
Kimura, Yuta [1 ]
Tomikawa, Tatsuki [1 ]
Sagawa, Morihiko [1 ]
Anan, Tomoe [1 ]
Watanabe, Reiko [1 ]
Tokuhira, Michihide [1 ]
Mori, Shigehisa [1 ]
Kizaki, Masahiro [1 ]
机构：
[1] Saitama Med Univ, Saitama Med Ctr, Dept Hematol, Saitama, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-21-1
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A Metabolically Optimized, Non-Cytotoxic Low-Dose Weekly Decitabine/Venetoclax Regimen in MDS and AML
    Levitz, David
    Fedorov, Kate
    Goldfinger, Mendel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S282 - S283
  • [22] The CAG regimen (low-dose cytarabine, aclarubicin hydrochloride and granulocyte colony-stimulating factor) for the treatment of elderly acute myelomonocytic leukaemia: A case study
    Tsuda, T
    Okamoto, Y
    Sakaguchi, R
    Katayama, N
    Ota, K
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2001, 29 (01) : 41 - 47
  • [23] Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid Leukemia
    Zeidan, Amer M.
    Schuster, Michael W.
    Krauter, Jurgen
    Maertens, Johan A.
    Gyan, Emmanuel
    Joris, Magalie
    Menne, Tobias F.
    Vyas, Paresh
    Ma, Weidong Wendy
    O'Connell, Ashleigh
    Zeremski, Mirjana
    Kudla, Arthur
    Chan, Geoffrey
    Sekeres, Mikkael A.
    BLOOD, 2019, 134
  • [24] Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast
    Joon Ho Moon
    Soo Jung Lee
    Yoo Jin Lee
    Byung Woog Kang
    Yee Soo Chae
    Jong Gwang Kim
    Jang Soo Suh
    Sang Kyun Sohn
    Annals of Hematology, 2012, 91 : 367 - 373
  • [25] Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast
    Moon, Joon Ho
    Lee, Soo Jung
    Lee, Yoo Jin
    Kang, Byung Woog
    Chae, Yee Soo
    Kim, Jong Gwang
    Suh, Jang Soo
    Sohn, Sang Kyun
    ANNALS OF HEMATOLOGY, 2012, 91 (03) : 367 - 373
  • [26] Clofarabine Plus Low-Dose Cytarabine Induction Followed by Consolidation with Clofarabine Plus Low-Dose Cytarabine Alternating with Decitabine as Frontline Therapy for Patients (pts) with Acute Myeloid Leukemia (AML) ≥ 60 Years (yrs)
    Parikh, Sameer A.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Kadia, Tapan
    Ravandi, Farhad
    Ferrajoli, Alessandra
    Estrov, Zeev
    Feliu, Jenny
    Faderl, Stefan
    BLOOD, 2009, 114 (22) : 813 - 813
  • [27] Epigenetic Priming with Decitabine Followed By Low-Dose Idarubicin Plus Cytarabine in AML Evolving from MDS or Higher Risk MDS: A Multicentre Phase 2 Single-Arm Trial
    Tong, Hongyan
    Zhou, Xinping
    Mei, Chen
    Zhang, Jin
    Lu, Ying
    Lan, Jianping
    Lin, Shengyun
    Zhuang, Yuefeng
    Kuang, Yuemin
    Ren, Yanling
    Ma, Liya
    Wei, Juying
    Ye, Li
    Xu, Weilai
    Li, Kongfei
    Lu, Chenxi
    Jin, Jie
    BLOOD, 2019, 134
  • [28] ORAL CLOFARABINE PLUS LOW-DOSE CYTARABINE IN PREVIOUSLY TREATED AML AND HIGH-RISK MDS PATIENTS=60 YEARS OF AGE
    Pagel, M.
    Sandhu, R.
    Gooley, T.
    Scott, B.
    Shannon-Dorcy, K.
    Dean, C.
    Appelbaum, R.
    Estey, H.
    HAEMATOLOGICA, 2012, 97 : 29 - 29
  • [29] High-Dose Cytarabine-Based Consolidation Shows Superior Results for Elderly AML Patients with Intermediate Risk Cytogenetics in First Complete Remission
    Hassanein, Mona Fawzy Ramadan
    Atenafu, Eshetu G.
    Gupta, Vikas
    Schuh, Andre C.
    Yee, Karen
    Minden, Mark D.
    Schimmer, Aaron D.
    Brandwein, Joseph M.
    BLOOD, 2012, 120 (21)
  • [30] Long-term results of a low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukemia and myelodysplastic syndrome in children with Down syndrome.
    Hitzler, J
    Al-Ahmari, A
    Shah, N
    Sung, L
    Zipursky, A
    BLOOD, 2005, 106 (11) : 328B - 328B
12345